Reclast Dosing Schedule: 5 mg Infusion Once a Year
[Dosing schedule · Reclast]

Reclast dosing schedule

zoledronic acid · intravenous infusion, 5 mg in 100 mL, once a year or once every 2 years · Label checked

Short answer: The Reclast label dose is a 5 mg infusion into a vein over at least 15 minutes, once a year for treating osteoporosis in women and men and for steroid-induced osteoporosis, once every 2 years for preventing postmenopausal osteoporosis, and once for Paget's disease. People drink at least 2 glasses of fluid beforehand. For a missed dose, the Medication Guide says to call to schedule the next one.

This is what the FDA label says. Follow your prescriber. Your prescriber may use a different dose or pace than the label's standard schedule.

What Reclast is approved for: Reclast is a bisphosphonate approved to treat and prevent osteoporosis in postmenopausal women, to increase bone mass in men with osteoporosis, to treat and prevent steroid (glucocorticoid)-induced osteoporosis in people taking 7.5 mg or more of prednisone a day for at least 12 months, and to treat Paget's disease of bone (sections 1.1 to 1.5). The label says the best length of use has not been set, and people at low fracture risk may be considered for stopping after 3 to 5 years (section 1.6).

Source
RECLAST (zoledronic acid) injection, for intravenous use, prescribing information and Medication Guide. Sandoz. DailyMed, version published February 13, 2026. DailyMed setid 5a9b3737-9ce6-4a89-b76e-6aab79eba9cf

How is Reclast taken?

Reclast is a 5 mg in 100 mL ready-to-infuse solution, given into a vein by a nurse or doctor over no less than 15 minutes at a constant rate, followed by a 10 mL saline flush (sections 2.1, 2.9, 3, 17).

People must be well hydrated first. The Medication Guide says to drink at least 2 glasses of fluid, such as water, within a few hours before the infusion, and eating beforehand is fine (sections 2.1, 17).

Before each dose, serum creatinine is checked and creatinine clearance is calculated. A routine oral exam is done before the first dose (section 2.7).

What is the Reclast dosing schedule on the label?

The table below is the label's schedule, from the Dosage and Administration section. Numbers are copied exactly; the section is in brackets.

Built from the text of sections 2.2 to 2.6 [Section 2.2]
UseDoseHow often
Treatment of osteoporosis in postmenopausal women5 mg infusion over no less than 15 minutesOnce a year
Prevention of osteoporosis in postmenopausal women5 mg infusion over no less than 15 minutesOnce every 2 years
Osteoporosis in men5 mg infusion over no less than 15 minutesOnce a year
Treatment and prevention of glucocorticoid-induced osteoporosis5 mg infusion over no less than 15 minutesOnce a year
Paget's disease of bone5 mg infusion over no less than 15 minutesSingle infusion; re-treatment may be considered after relapse

Other dosing rules on the label

  • Section 2.7

    Reclast is not given with creatinine clearance under 35 mL/min or signs of acute kidney impairment. At 35 mL/min or more, no dose change is needed.

  • Section 2.8

    For Paget's disease, everyone takes 1500 mg elemental calcium a day in divided doses (750 mg twice a day or 500 mg three times a day) and 800 international units of vitamin D, particularly in the 2 weeks after the infusion.

  • Section 2.8

    For osteoporosis, calcium and vitamin D supplements are taken if diet is not enough; an average of at least 1200 mg calcium and 800 to 1000 international units vitamin D daily is recommended.

  • Section 2.1

    Acetaminophen after the infusion may reduce acute phase reaction symptoms.

  • Section 1.6

    The need to continue is reviewed periodically. People at low fracture risk may be considered for stopping after 3 to 5 years, and fracture risk is rechecked periodically after stopping.

  • Section 8.1

    Reclast is stopped when pregnancy is recognized.

What does the label say about a missed dose?

  • Medication Guide

    The Medication Guide says: if you miss a dose of Reclast, call your doctor or healthcare provider to schedule your next dose. The prescribing information gives no separate missed-dose rule.

More on this: missed a dose of Reclast.

What does the label say about switching?

  • Section 5.1

    People being treated with Zometa, which contains the same active ingredient, are not given Reclast.

How can Dose Track follow this schedule?

In Dose Track you set up Reclast as a protocol with the dose and schedule your prescriber gave you. A protocol can hold dose steps, each with its own dose and length in days or weeks, so a step-up plan like the one on the label can be entered once and the app moves to the next step on its own. Reminders follow the schedule, and every dose is logged with the date and time, so you can see which step you are on and when your last dose was. The app follows what you enter; it does not choose or change a dose.

This page is what the FDA label says, in plain words. It is not medical advice. Follow your prescriber, and ask them or your pharmacist about anything here.

Dosing schedules for similar medicines

Frequently asked questions

How often is Reclast given?+
Once a year to treat osteoporosis in women and men and for steroid-induced osteoporosis, once every 2 years to prevent postmenopausal osteoporosis, and as a single infusion for Paget's disease (sections 2.2 to 2.6).
How long does a Reclast infusion take?+
No less than 15 minutes, at a constant rate, followed by a 10 mL saline flush of the line (sections 2.1, 2.9).
What if a Reclast dose is missed?+
The Medication Guide says to call your doctor or healthcare provider to schedule your next dose.
Should I drink water before Reclast?+
The Medication Guide says to drink at least 2 glasses of fluid, such as water, within a few hours before the infusion, as directed by your doctor, to lower the risk of kidney problems. Eating beforehand is fine (section 17).
How long is Reclast used for osteoporosis?+
The label says the best length of use has not been set and its data cover three years. People at low fracture risk may be considered for stopping after 3 to 5 years (section 1.6).